 
MAINE STATE LEGISLATURE  
 
 
 
The following document is provided by the 
LAW AND LEGISLATIVE DIGITAL LIBRARY  
at the Maine State Law and Legislative Reference Library 
http://legislature.m aine.gov/lawlib 
 
 
 
 
 
 
 
 
 
 
Reproduced from electronic originals 
(may include minor formatting diffe rences from printed original) 
 
 
Printed on recycled paper   
127th MAINE LEGISLATURE  
 
FIRST REGULAR SESSION -2015  
 
Legislative Document  No. 327  
H.P. 221  House of Representatives, February 10, 2015  
 
 
An Act To Require Prescribers of Controlled Substances To Use the 
Controlled Substances Prescription Monitoring Program Software  
 
 
 
 
Reference to the Committee on Health and Human Services suggested and ordered printed.  
 
 
  
 ROBERT B. HUNT  
 Clerk  
 
Presented by Representative PICCHIOTTI of Fairfield.  
Cosponsored by Representatives:  GUERIN of Glenburn, LOCKMAN of Amherst, SAWICKI 
of Auburn, WARD of Dedham.  
 
 

 
 Page 1 - 127LR0384(01) -1 
 Be it enacted by the People of the State of Maine as follows:  1 
Sec. 1.  22 MRSA ยง7250 -A is enacted to read:  2 
ยง7250 -A.  Required use of prescription monitoring information  3 
After December 31, 2015, a prescriber may not prescribe a controlled substance to a 4 
patient or authorize a refill of an existing prescription of a controlled substance for a 5 
patient prior to obtaining, in accordance with rules adopted by the department, any 6 
available prescription monitoring information related to the patient.  7 
Sec. 2.  22 MRS A ยง7251, sub -ยง1-A is enacted to read:  8 
1-A.  Failure to comply with use requirement.   A prescriber is subject to discipline 9 
by the applicable professional licensing entity if the prescriber fails to obtain any 10 
available prescription monitoring information r elated to a patient prior to prescribing a 11 
controlled substance or authorizing a refill of an existing prescription of a controlled 12 
substance as required by section 7250 -A. 13 
SUMMARY  14 
This bill requires, beginning January 1, 2016, prescribers of controlled su bstances to 15 
obtain any available prescription monitoring information from the Controlled Substances 16 
Prescription Monitoring Program established by the Department of Health and Human 17 
Services related to a patient before prescribing or authorizing a refill o f a prescription of a 18 
controlled substance to the patient.  19 
 
